These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8580272)

  • 21. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
    Schütze K; Hentschel E
    Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study.
    Ekström P; Carling L; Unge P; Anker-Hansen O; Sjöstedt S; Sellström H
    Scand J Gastroenterol; 1995 Mar; 30(3):210-5. PubMed ID: 7770708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lansoprazole is superior to ranitidine as maintenance treatment for the prevention of duodenal ulcer relapse.
    Bardhan KD; Crowe J; Thompson RP; Trewby PN; Keeling PN; Weir D; Crouch SL
    Aliment Pharmacol Ther; 1999 Jun; 13(6):827-32. PubMed ID: 10383514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid healing of gastric ulcers with lansoprazole.
    Bardhan KD; Ahlberg J; Hislop WS; Lindholmer C; Long RG; Morgan AG; Sjostedt S; Smith PM; Stig R; Wormsley KG
    Aliment Pharmacol Ther; 1994 Apr; 8(2):215-20. PubMed ID: 8038354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
    Brunner G; Arnold R; Hennig U; Fuchs W
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():51-5, discussion 61-6. PubMed ID: 8490080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
    Agrawal NM; Campbell DR; Safdi MA; Lukasik NL; Huang B; Haber MM
    Arch Intern Med; 2000 May; 160(10):1455-61. PubMed ID: 10826458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
    Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia.
    Jones R; Crouch SL
    Aliment Pharmacol Ther; 1999 Mar; 13(3):413-9. PubMed ID: 10102976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute treatment of duodenal ulcer: experience with lansoprazole.
    Mignon M; Vallot T
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():37-40, discussion 61-6. PubMed ID: 8490078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A trial of lansoprazole in refractory gastric ulcer.
    van Rensburg CJ; Louw JA; Girdwood AH; Simjee AE; Marks IN
    Aliment Pharmacol Ther; 1996 Jun; 10(3):381-6. PubMed ID: 8791967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lansoprazole on peptic ulcers.
    Ohashi T; Sakata J; Haraguchi Y; Eto T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study.
    Dekkers CP; Beker JA; Thjodleifsson B; Gabryelewicz A; Bell NE; Humphries TJ
    Aliment Pharmacol Ther; 1999 Feb; 13(2):179-86. PubMed ID: 10102948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM; Faulds D
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB; Faulds D; McTavish D
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
    Avner DL; Movva R; Nelson KJ; McFarland M; Berry W; Erfling W
    Am J Gastroenterol; 1995 Aug; 90(8):1289-94. PubMed ID: 7639232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.